Form 4: TransMedics Officer Sells Shares for Tax Obligations

TransMedics Group's Senior VP, General Counsel, and Secretary, Anil P. Ranganath, sold 864 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Anil P. Ranganath, Senior Vice President, General Counsel, and Secretary of TransMedics Group, Inc. (TMDX), reported a transaction.
• On March 2, 2026, Ranganath disposed of 864 shares of TransMedics Group common stock.
• The shares were sold at a price of $139.12 per share.
• This sale was a 'sell to cover' transaction, executed to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following this transaction, Ranganath beneficially owns 13,091 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event because it is a non-discretionary, tax-related sale of shares, which is a common occurrence for executives receiving equity compensation and does not reflect a change in the officer's investment sentiment.

Positives

• The transaction is a routine, non-discretionary sale to cover tax liabilities, which is a common practice for executives receiving equity compensation.
• The officer retains a significant equity stake of 13,091 shares after the sale, indicating continued alignment with shareholder interests.

Future Outlook

na

Management Comments

• The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction pursuant to the terms of the RSU award.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are common for executives receiving equity compensation, as they are a standard mechanism to manage tax liabilities upon the vesting of restricted stock units. This type of transaction is generally not interpreted as a signal of management's sentiment regarding the company's future prospects, unlike open market discretionary sales.

Comparison to Industry Standards

• Sell-to-cover transactions are a standard practice across industries for executives receiving equity compensation, aligning with typical tax planning strategies for vested restricted stock units.
• Many executives at peer medical device companies, such as Intuitive Surgical (ISRG) or Medtronic (MDT), frequently execute similar tax-related sales upon RSU vesting.
• The proportion of shares sold (864 out of a total holding of 13,091) is consistent with covering tax obligations without significantly reducing the officer's overall equity stake.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related sale, not a discretionary divestment, and the officer retains a significant equity stake.
• Employees: No direct impact.

Key Dates

Recommendation

This Form 4 reports a routine 'sell to cover' transaction by an executive to satisfy tax obligations on vested restricted stock units. Such sales are non-discretionary and do not typically signal a change in the company's fundamentals or the executive's long-term outlook. Therefore, it provides no new information to warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

TransMedics Group, TMDX, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Sell to Cover, Anil P. Ranganath, Corporate Officer